Literature DB >> 20541169

Pain/Depression dyad: a key to a better understanding and treatment of functional somatic syndromes.

Don L Goldenberg1.   

Abstract

Functional somatic syndromes include some of the most common and frustrating illnesses seen by primary care physicians and medical specialists. An extensive literature search of the 2 best characterized functional somatic syndromes, fibromyalgia and irritable bowel syndrome, reveals the overlap of these 2 disorders and their close relationship to depression. New pathophysiologic studies have shown that there are similar central nervous system changes in fibromyalgia, irritable bowel syndrome, and depression. These clinical and biologic similarities are consistent with the observations that the effective management of fibromyalgia and irritable bowel syndrome is comparable to that of depression. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541169     DOI: 10.1016/j.amjmed.2010.01.014

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  34 in total

1.  Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.

Authors:  S Stevens Negus; Marisa B Rosenberg; Ahmad A Altarifi; Robert H O'Connell; John E Folk; Kenner C Rice
Journal:  J Pain       Date:  2012-03-15       Impact factor: 5.820

Review 2.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

3.  A Moderated Mediation Analysis on the Association Between Perceived Discrimination and Physical Symptoms Among Immigrant Women from Mainland China into Hong Kong: Evidence from the FAMILY Cohort.

Authors:  Nancy Xiaonan Yu; Michael Y Ni; Sunita M Stewart
Journal:  J Immigr Minor Health       Date:  2021-06

Review 4.  Alleviating pain with delta opioid receptor agonists: evidence from experimental models.

Authors:  Sophie Berthiaume; Khaled Abdallah; Véronique Blais; Louis Gendron
Journal:  J Neural Transm (Vienna)       Date:  2020-03-18       Impact factor: 3.575

5.  [Therapeutic relationship and communication. Attitude towards patients with functional pain syndromes].

Authors:  C Hausteiner-Wiehle; R Schaefert
Journal:  Z Gerontol Geriatr       Date:  2014-02       Impact factor: 1.281

Review 6.  [Therapeutic relationship and communication. Attitude towards patients with functional pain syndromes].

Authors:  C Hausteiner-Wiehle; R Schaefert
Journal:  Schmerz       Date:  2013-08       Impact factor: 1.107

7.  Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses.

Authors:  Ying Xu; Lu Zhang; Tuo Shao; Lina Ruan; Lin Wang; Jiao Sun; Jianxin Li; Xinbo Zhu; James M O'Donnell; Jianchun Pan
Journal:  Metab Brain Dis       Date:  2013-04-14       Impact factor: 3.584

8.  Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.

Authors:  Marisa B Rosenberg; F Ivy Carroll; S Stevens Negus
Journal:  J Pain       Date:  2013-01-16       Impact factor: 5.820

Review 9.  Expression and treatment of pain-related behavioral depression.

Authors:  S Stevens Negus
Journal:  Lab Anim (NY)       Date:  2013-08       Impact factor: 12.625

Review 10.  Novel Pharmacological Nonopioid Therapies in Chronic Pain.

Authors:  Alan David Kaye; Elyse M Cornett; Brendon Hart; Shilpadevi Patil; Andrew Pham; Matthew Spalitta; Kenneth F Mancuso
Journal:  Curr Pain Headache Rep       Date:  2018-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.